Recently, it has been shown that Notch mediates growth arrest and apoptosis in AML cells via activation of Hairy/Enhancer of Split 1 (HES1), suggesting the development of Notch agonists as a new therapy [24]. The gene discussed is HES1; the disease is acute myeloid leukemia.